Aspire Biopharma Holdings, INC. (ASBP) — 10-K/A Filings
All 10-K/A filings from Aspire Biopharma Holdings, INC.. Browse 1 Amended Annual Report reports with AI-powered summaries and risk analysis.
10-K/A Filings (1)
-
Aspire Biopharma Files Amended 2025 Annual Report
— Apr 8, 2026 Risk: low
Aspire Biopharma Holdings, Inc. filed an amended 10-K report on April 8, 2026, for the fiscal year ending December 31, 2025. The filing includes various exhibit
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX